Category: Biosimilars


Biogeneric infliximab now available in Europe 
Posted on Sep 10, 2013

    Today we learn that a biogeneric form of Remicade, the first biogeneric monoclonal antibody, will shortly be available in Europe: Tuesday’s final green light for Inflectra – which was developed by South Korea’s Celltrion and will be marketed by U.S. company Hospira – had been expected following a European Medicines Agency recommendation in Read More »

Biocon Mylan Biogenerics Partnership 
Posted on Feb 14, 2013

Today we learn that generics giant Mylan has entered into a partnership with India-based Biocon to focus on insulin analog biosimilars: Under the terms of this collaboration, Mylan will have the rights to develop and market Biocon’s Glargine (the generic version of Sanofi’s Lantus┬«), Lispro (the generic version of Eli Lilly’s Humalog┬«) and Aspart (the Read More »

Google Plus   Facebook   Twitter
Powered By : Supra International Inc.